These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6327849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
    Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW.
    Sex Transm Dis; 1985; 12(4):215-8. PubMed ID: 3001952
    [Abstract] [Full Text] [Related]

  • 3. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
    Ashley RL, Corey L.
    J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
    [Abstract] [Full Text] [Related]

  • 4. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D, Morag A, Or R, Naparstek E, Cividalli G, Ruchlemer R, Aker M, Maayan S, Slavin S.
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [Abstract] [Full Text] [Related]

  • 5. Serological assessment of acyclovir treatment of herpes genitalis.
    Ragab NF, Habib MA, Ghozzi MY.
    Arch Androl; 1989 Mar; 23(2):147-53. PubMed ID: 2556084
    [Abstract] [Full Text] [Related]

  • 6. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
    Redding SW, Montgomery MT.
    Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
    Bernstein DI, Stanberry LR, Harrison CJ, Kappes JC, Myers MG.
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections.
    Frenkel L, Pineda E, Garratty E, Fall H, Dillon M, Bryson Y.
    J Infect Dis; 1989 May; 159(5):845-50. PubMed ID: 2540245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P, Wilczek H, Gahrton G, Gustavsson A, Lundgren G, Lönnqvist B, Ringdén O, Wahren B.
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of a herpes simplex subunit vaccine.
    Cappel R, Sprecher S, De Cuyper F, De Braekeleer J.
    J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD, McLaren C, Barry DW.
    Am J Med; 1982 Jul 20; 73(1A):372-5. PubMed ID: 6285725
    [Abstract] [Full Text] [Related]

  • 16. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF, Cornelissen JJ, Smit J, Lepoutre J, de Gast GC, Dekker AW, Rozenberg-Arska M.
    Bone Marrow Transplant; 1993 Feb 20; 11(2):177-9. PubMed ID: 8382096
    [Abstract] [Full Text] [Related]

  • 17. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B, Chebbi F, Lefrere F, Ait Arkoub Z, Varet B, Fillet AM.
    Bone Marrow Transplant; 2001 Oct 20; 28(8):799-801. PubMed ID: 11781635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
    Wade JC, McLaren C, Meyers JD.
    J Infect Dis; 1983 Dec 20; 148(6):1077-82. PubMed ID: 6317768
    [Abstract] [Full Text] [Related]

  • 20. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.
    Whitley RJ, Levin M, Barton N, Hershey BJ, Davis G, Keeney RE, Whelchel J, Diethelm AG, Kartus P, Soong SJ.
    J Infect Dis; 1984 Sep 20; 150(3):323-9. PubMed ID: 6090539
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.